007570 — Ilyang Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Market Cap
KR₩224bn
Enterprise Value
KR₩324bn
Revenue
KR₩269bn

Annual balance sheet for Ilyang Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	41,610	81,924	64,825	12,813	11,818
Net Total Accounts Receivable
Net Total Receivables	64,945	69,518	67,595	52,336	48,897
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	162,496	203,560	200,728	123,659	125,370
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	185,671	197,309	198,019	181,973	216,421
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	439,117	494,271	498,185	392,607	431,211
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	177,147	198,210	186,859	139,263	156,902
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	231,923	270,157	263,532	165,743	193,217
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	207,194	224,115	234,654	226,864	237,994
Total Liabilities & Shareholders' Equity	439,117	494,271	498,185	392,607	431,211
Total Common Shares Outstanding
Total Preferred Shares Outstanding